Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.9M Buy
202,120
+4,766
+2% +$550K 4.29% 2
2026
Q1
$23.6M Sell
197,354
-11,889
-6% -$1.56M 4.17% 8
2025
Q4
$28.8M Sell
209,243
-27,622
-12% -$3.97M 4.33% 8
2025
Q3
$34.9M Sell
236,865
-2,143
-0.9% -$297K 5.22% 1
2025
Q2
$30.9M Sell
239,008
-31,143
-12% -$3.77M 4.39% 4
2025
Q1
$32.3M Buy
270,151
+262,665
+3,509% +$32.6M 4.55% 2
2024
Q4
$871K Hold
7,486
0.13% 25
2024
Q3
$751K Sell
7,486
-736
-9% -$98.5K 1.45% 23
2024
Q2
$888K Buy
8,222
+3,878
+89% +$528K 0.47% 19
2024
Q1
$446K Hold
4,344
0.24% 22
2023
Q4
$497K Buy
+4,344
New +$434K 0.18% 29

Other funds holding XYL

Foresight Group's XYL Position: Q2 2026 in Review

Foresight Group increased its Xylem (XYL) stake by 2.4% in Q2 2026, buying an estimated $550K and bringing the position to 202,120 shares worth $23.9M. The position accounts for 4.29% of the portfolio, ranked #2.

Foresight Group first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $34.9M in Q3 2025. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Foresight Group held 202,120 shares of Xylem worth $23.9M as of Q2 2026.
  • Foresight Group bought 4,766 Xylem shares in Q2 2026, an estimated $550K.
  • Xylem made up 4.29% of Foresight Group's portfolio in Q2 2026, its #2 holding.
  • Foresight Group first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • Foresight Group's Xylem position peaked at $34.9M in Q3 2025.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.